Neuropeptides and asthma
- PMID: 9526900
- DOI: 10.1097/00063198-199801000-00004
Neuropeptides and asthma
Abstract
Although asthma is considered to be an inflammatory disease of the airways, neural mechanisms remain very important. Neural control of airways is far more complex than has been previously recognized. In addition to the classic neural pathways, the nonadrenergic, noncholinergic pathway has been described in the airways of animals and humans. Neuropeptides are present in sensory, parasympathetic, and sympathetic neurons in airways, and have been shown to have proinflammatory effects, such as increased mucus production, microvascular leakage, and smooth muscle contraction. Neuropeptides released from sensory nerves (eg, neurokinin A and substance P) mediate excitatory nonadrenergic, noncholinergic transmission, which causes bronchoconstriction and, possibly, bronchial hyperresponsiveness. Better understanding of neural mechanisms might provide a useful therapeutic approach in the future.
Similar articles
-
Autonomic innervation of human airways: structure, function, and pathophysiology in asthma.Neuroimmunomodulation. 1999 May-Jun;6(3):145-59. doi: 10.1159/000026376. Neuroimmunomodulation. 1999. PMID: 10213912 Review.
-
Neural control of human airways in health and disease.Am Rev Respir Dis. 1986 Dec;134(6):1289-314. doi: 10.1164/arrd.1986.134.5.1289. Am Rev Respir Dis. 1986. PMID: 3538958 Review.
-
Cholinergic and neurogenic mechanisms in obstructive airways disease.Am J Med. 1986 Nov 14;81(5A):93-102. doi: 10.1016/0002-9343(86)90470-5. Am J Med. 1986. PMID: 2878614 Review.
-
Neuropeptides in human airways: function and clinical implications.Am Rev Respir Dis. 1987 Dec;136(6 Pt 2):S77-83. doi: 10.1164/ajrccm/136.6_Pt_2.S77. Am Rev Respir Dis. 1987. PMID: 2446545 Review.
-
Neuropeptides and asthma.Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S28-32. doi: 10.1164/ajrccm/143.3_Pt_2.S28. Am Rev Respir Dis. 1991. PMID: 1706152 Review.
Cited by
-
Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections?Microbes Infect. 2006 Jan;8(1):285-93. doi: 10.1016/j.micinf.2005.07.001. Epub 2005 Aug 10. Microbes Infect. 2006. PMID: 16182587 Free PMC article. Review.
-
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P.J Virol. 2003 Jun;77(11):6580-4. doi: 10.1128/jvi.77.11.6580-6584.2003. J Virol. 2003. PMID: 12743318 Free PMC article.
-
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family.EMBO J. 2000 Aug 1;19(15):4046-55. doi: 10.1093/emboj/19.15.4046. EMBO J. 2000. PMID: 10921885 Free PMC article.
-
Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.J Virol. 2000 Feb;74(4):1614-22. doi: 10.1128/jvi.74.4.1614-1622.2000. J Virol. 2000. PMID: 10644330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical